Somatostatin D Cells, also known as delta cells, are a type of endocrine cell found in the pancreatic islets (Islets of Langerhans). These cells play a crucial role in regulating the endocrine function of the pancreas by producing the hormone somatostatin. Somatostatin acts as an inhibitory hormone, regulating the release of various hormones such as insulin and glucagon from neighboring alpha and beta cells in the islets. It exerts its effects by suppressing the secretion of these hormones, thus playing a key role in glucose homeostasis and overall metabolic regulation. The somatostatin D cells are characterized by their distinctive delta-cell morphology and are interspersed among the alpha and beta cells in the pancreatic islets. Delta cells are responsive to changes in blood glucose levels, amino acids, and other factors that influence hormone secretion. The inhibitory actions of somatostatin extend beyond the pancreas, affecting other organs such as the gastrointestinal tract, where it regulates the secretion of various digestive enzymes and inhibits gastric acid release. Somatostatin D cells contribute to the maintenance of physiological balance and prevent excessive hormonal fluctuations, helping to ensure stability in metabolic processes. Dysregulation of somatostatin secretion may be associated with disorders like diabetes mellitus. Research on somatostatin D cells provides insights into their role in endocrine regulation and potential therapeutic applications. Somatostatin analogs are used in clinical settings to treat conditions like acromegaly and neuroendocrine tumors, highlighting the clinical significance of understanding delta cell function and somatostatin biology.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy